The tweet was deleted by the author.
But we saved everything 🙂.
Goldman Sachs reports that Ben Silver, Co-CIO of Maverick Capital, sees potential for a capital expenditure surge in the life science tools sector as artificial intelligence and reshoring reshape the healthcare industry.
Silver explained on Exchanges: Great Investors that drug manufacturing could be entering a revision cycle as operations return to the U.S. The stock could react as these factors drive changes in the sector.
Goldman Sachs ($GS) is trading sharply below the SMA-20 ($1,060.54), but remains above the SMA-50 ($990.87) and well above the SMA-200 ($884.83), signaling short-term downside pressure within a still intact medium- and long-term uptrend structure. The Ichimoku Kijun on D1 stands at $1,031.22, marking immediate resistance. Near-term support is found at the SMA-50 ($990.87), with key support at the SMA-200 ($884.83), while resistance levels are set by the Ichimoku Kijun ($1,031.22) and the SMA-20 ($1,060.54).
Momentum indicators on D1 show a mixed to bearish bias: MACD signals strong buying but ADX remains below 25, suggesting direction lacks conviction. RSI (45.80), Stoch RSI (0.00), and CCI (–94.79) all point to the asset being oversold, supported by deeply negative BBP (–21.40), confirming that seller momentum dominates. The Awesome Oscillator remains neutral, failing to support a clear trend direction. Goldman Sachs has fallen $80.20 (7.30%) over the past week, dropping from a previous close of $1,098.66 and currently sits at the very bottom of its weekly range, with volatility standing at 9.90%. This marks a pronounced, steady decline through the week. In today’s session, the stock has dropped 4.38% from its open, accentuating ongoing downside momentum.
Looking ahead, the expected range for the coming week is $1,015 to $1,070, keeping price action well above the 52-week low of $691.30 but below the recent high of $1,121.95. With W1 indicators giving “Buy” signals across MA-50, RSI, ADX, and MACD, the probability of a price increase is very high (more than 80%), making further declines less likely. The baseline scenario is for consolidation between support and resistance as sellers exhaust momentum. A bullish move would require a decisive break above $1,031, opening the way to the upper range. A bearish breakdown below $990 would expose the longer-term support near $885, though the strong weekly structure favors stabilization and potential rebound.
Previously it was reported that Goldman Sachs faced significant selling pressure but was expected to find support and stabilize in the near term. The current analysis provides an updated perspective on market dynamics, highlighting a key level for traders to monitor as the stock tests critical support amid evolving sentiment.